nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxazosin—ABCB1—Mitomycin—urinary bladder cancer	0.131	0.474	CbGbCtD
Doxazosin—ADRA1B—vas deferens—urinary bladder cancer	0.075	0.372	CbGeAlD
Doxazosin—ABCB1—Gemcitabine—urinary bladder cancer	0.0378	0.136	CbGbCtD
Doxazosin—ABCB1—Cisplatin—urinary bladder cancer	0.0275	0.0991	CbGbCtD
Doxazosin—ABCB1—Etoposide—urinary bladder cancer	0.027	0.0974	CbGbCtD
Doxazosin—ABCB1—Doxorubicin—urinary bladder cancer	0.0184	0.0664	CbGbCtD
Doxazosin—ABCB1—Methotrexate—urinary bladder cancer	0.0178	0.0643	CbGbCtD
Doxazosin—CYP2D6—Doxorubicin—urinary bladder cancer	0.0173	0.0626	CbGbCtD
Doxazosin—Prazosin—MT3—urinary bladder cancer	0.0152	1	CrCbGaD
Doxazosin—KCNH6—prostate gland—urinary bladder cancer	0.0118	0.0586	CbGeAlD
Doxazosin—CYP2C19—urine—urinary bladder cancer	0.0106	0.0526	CbGeAlD
Doxazosin—KCNH6—renal system—urinary bladder cancer	0.00806	0.0399	CbGeAlD
Doxazosin—ADRA1D—prostate gland—urinary bladder cancer	0.00655	0.0325	CbGeAlD
Doxazosin—KCNH6—female reproductive system—urinary bladder cancer	0.00646	0.032	CbGeAlD
Doxazosin—CYP2D6—urine—urinary bladder cancer	0.00617	0.0306	CbGeAlD
Doxazosin—ORM1—prostate gland—urinary bladder cancer	0.0054	0.0267	CbGeAlD
Doxazosin—ADRA1D—epithelium—urinary bladder cancer	0.00481	0.0238	CbGeAlD
Doxazosin—ADRA1B—renal system—urinary bladder cancer	0.00456	0.0226	CbGeAlD
Doxazosin—ADRA1D—urethra—urinary bladder cancer	0.00439	0.0217	CbGeAlD
Doxazosin—ADRA1A—prostate gland—urinary bladder cancer	0.00376	0.0186	CbGeAlD
Doxazosin—KCNH2—prostate gland—urinary bladder cancer	0.00363	0.018	CbGeAlD
Doxazosin—ADRA1D—female reproductive system—urinary bladder cancer	0.00358	0.0177	CbGeAlD
Doxazosin—KCNH2—seminal vesicle—urinary bladder cancer	0.00307	0.0152	CbGeAlD
Doxazosin—ORM1—female reproductive system—urinary bladder cancer	0.00295	0.0146	CbGeAlD
Doxazosin—ADRA2A—prostate gland—urinary bladder cancer	0.00286	0.0142	CbGeAlD
Doxazosin—ADRA1A—epithelium—urinary bladder cancer	0.00277	0.0137	CbGeAlD
Doxazosin—ADRA1A—renal system—urinary bladder cancer	0.00256	0.0127	CbGeAlD
Doxazosin—KCNH2—renal system—urinary bladder cancer	0.00248	0.0123	CbGeAlD
Doxazosin—KCNH2—urethra—urinary bladder cancer	0.00243	0.0121	CbGeAlD
Doxazosin—ADRA2A—seminal vesicle—urinary bladder cancer	0.00242	0.012	CbGeAlD
Doxazosin—KCNH2—female reproductive system—urinary bladder cancer	0.00198	0.00983	CbGeAlD
Doxazosin—ADRA2A—urethra—urinary bladder cancer	0.00192	0.00949	CbGeAlD
Doxazosin—CYP2C19—vagina—urinary bladder cancer	0.00188	0.00932	CbGeAlD
Doxazosin—KCNH2—vagina—urinary bladder cancer	0.00179	0.00889	CbGeAlD
Doxazosin—ORM1—lymph node—urinary bladder cancer	0.00172	0.00853	CbGeAlD
Doxazosin—ABCB1—prostate gland—urinary bladder cancer	0.00159	0.0079	CbGeAlD
Doxazosin—ADRA2A—female reproductive system—urinary bladder cancer	0.00156	0.00774	CbGeAlD
Doxazosin—CYP2D6—renal system—urinary bladder cancer	0.00151	0.00748	CbGeAlD
Doxazosin—ADRA2A—vagina—urinary bladder cancer	0.00141	0.007	CbGeAlD
Doxazosin—ABCB1—seminal vesicle—urinary bladder cancer	0.00135	0.00668	CbGeAlD
Doxazosin—CYP2D6—female reproductive system—urinary bladder cancer	0.00121	0.00599	CbGeAlD
Doxazosin—ABCB1—epithelium—urinary bladder cancer	0.00117	0.0058	CbGeAlD
Doxazosin—KCNH2—lymph node—urinary bladder cancer	0.00116	0.00575	CbGeAlD
Doxazosin—ABCB1—renal system—urinary bladder cancer	0.00109	0.00538	CbGeAlD
Doxazosin—ABCB1—urethra—urinary bladder cancer	0.00107	0.00529	CbGeAlD
Doxazosin—ADRA2A—lymph node—urinary bladder cancer	0.000914	0.00453	CbGeAlD
Doxazosin—ABCB1—female reproductive system—urinary bladder cancer	0.00087	0.00431	CbGeAlD
Doxazosin—ABCB1—vagina—urinary bladder cancer	0.000787	0.0039	CbGeAlD
Doxazosin—ABCB1—lymph node—urinary bladder cancer	0.000509	0.00252	CbGeAlD
Doxazosin—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	0.000306	0.000616	CcSEcCtD
Doxazosin—Weight increased—Doxorubicin—urinary bladder cancer	0.000305	0.000614	CcSEcCtD
Doxazosin—Epistaxis—Epirubicin—urinary bladder cancer	0.000304	0.000614	CcSEcCtD
Doxazosin—Pruritus—Gemcitabine—urinary bladder cancer	0.000304	0.000613	CcSEcCtD
Doxazosin—Nausea—Thiotepa—urinary bladder cancer	0.000304	0.000612	CcSEcCtD
Doxazosin—Weight decreased—Doxorubicin—urinary bladder cancer	0.000303	0.000611	CcSEcCtD
Doxazosin—Sinusitis—Epirubicin—urinary bladder cancer	0.000303	0.00061	CcSEcCtD
Doxazosin—Feeling abnormal—Etoposide—urinary bladder cancer	0.000303	0.00061	CcSEcCtD
Doxazosin—Hyperglycaemia—Doxorubicin—urinary bladder cancer	0.000302	0.000609	CcSEcCtD
Doxazosin—Pneumonia—Doxorubicin—urinary bladder cancer	0.0003	0.000605	CcSEcCtD
Doxazosin—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.0003	0.000605	CcSEcCtD
Doxazosin—Pruritus—Fluorouracil—urinary bladder cancer	0.000299	0.000603	CcSEcCtD
Doxazosin—Drowsiness—Doxorubicin—urinary bladder cancer	0.000299	0.000602	CcSEcCtD
Doxazosin—Visual impairment—Methotrexate—urinary bladder cancer	0.000298	0.000601	CcSEcCtD
Doxazosin—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000295	0.000595	CcSEcCtD
Doxazosin—Bradycardia—Epirubicin—urinary bladder cancer	0.000295	0.000594	CcSEcCtD
Doxazosin—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000294	0.000593	CcSEcCtD
Doxazosin—Urticaria—Etoposide—urinary bladder cancer	0.000292	0.000588	CcSEcCtD
Doxazosin—Jaundice—Doxorubicin—urinary bladder cancer	0.000291	0.000587	CcSEcCtD
Doxazosin—Rhinitis—Epirubicin—urinary bladder cancer	0.00029	0.000585	CcSEcCtD
Doxazosin—Body temperature increased—Etoposide—urinary bladder cancer	0.00029	0.000585	CcSEcCtD
Doxazosin—Abdominal pain—Etoposide—urinary bladder cancer	0.00029	0.000585	CcSEcCtD
Doxazosin—Conjunctivitis—Doxorubicin—urinary bladder cancer	0.00029	0.000585	CcSEcCtD
Doxazosin—Urinary tract infection—Doxorubicin—urinary bladder cancer	0.00029	0.000585	CcSEcCtD
Doxazosin—Hepatitis—Epirubicin—urinary bladder cancer	0.00029	0.000584	CcSEcCtD
Doxazosin—Eye disorder—Methotrexate—urinary bladder cancer	0.000289	0.000583	CcSEcCtD
Doxazosin—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000289	0.000583	CcSEcCtD
Doxazosin—Tinnitus—Methotrexate—urinary bladder cancer	0.000289	0.000582	CcSEcCtD
Doxazosin—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000288	0.000581	CcSEcCtD
Doxazosin—Asthenia—Cisplatin—urinary bladder cancer	0.000288	0.00058	CcSEcCtD
Doxazosin—Pharyngitis—Epirubicin—urinary bladder cancer	0.000288	0.00058	CcSEcCtD
Doxazosin—Sweating—Doxorubicin—urinary bladder cancer	0.000286	0.000577	CcSEcCtD
Doxazosin—Haematuria—Doxorubicin—urinary bladder cancer	0.000285	0.000574	CcSEcCtD
Doxazosin—Epistaxis—Doxorubicin—urinary bladder cancer	0.000282	0.000568	CcSEcCtD
Doxazosin—Sinusitis—Doxorubicin—urinary bladder cancer	0.00028	0.000565	CcSEcCtD
Doxazosin—Dizziness—Fluorouracil—urinary bladder cancer	0.00028	0.000564	CcSEcCtD
Doxazosin—Visual impairment—Epirubicin—urinary bladder cancer	0.000279	0.000563	CcSEcCtD
Doxazosin—Chills—Methotrexate—urinary bladder cancer	0.000278	0.00056	CcSEcCtD
Doxazosin—Diarrhoea—Cisplatin—urinary bladder cancer	0.000274	0.000553	CcSEcCtD
Doxazosin—Alopecia—Methotrexate—urinary bladder cancer	0.000274	0.000551	CcSEcCtD
Doxazosin—Vomiting—Gemcitabine—urinary bladder cancer	0.000273	0.000551	CcSEcCtD
Doxazosin—Bradycardia—Doxorubicin—urinary bladder cancer	0.000273	0.00055	CcSEcCtD
Doxazosin—Mental disorder—Methotrexate—urinary bladder cancer	0.000271	0.000547	CcSEcCtD
Doxazosin—Rash—Gemcitabine—urinary bladder cancer	0.000271	0.000546	CcSEcCtD
Doxazosin—Dermatitis—Gemcitabine—urinary bladder cancer	0.000271	0.000546	CcSEcCtD
Doxazosin—Eye disorder—Epirubicin—urinary bladder cancer	0.000271	0.000546	CcSEcCtD
Doxazosin—Hypersensitivity—Etoposide—urinary bladder cancer	0.000271	0.000545	CcSEcCtD
Doxazosin—Tinnitus—Epirubicin—urinary bladder cancer	0.00027	0.000544	CcSEcCtD
Doxazosin—Malnutrition—Methotrexate—urinary bladder cancer	0.00027	0.000543	CcSEcCtD
Doxazosin—Headache—Gemcitabine—urinary bladder cancer	0.000269	0.000543	CcSEcCtD
Doxazosin—Flushing—Epirubicin—urinary bladder cancer	0.000269	0.000542	CcSEcCtD
Doxazosin—Vomiting—Fluorouracil—urinary bladder cancer	0.000269	0.000542	CcSEcCtD
Doxazosin—Rhinitis—Doxorubicin—urinary bladder cancer	0.000269	0.000542	CcSEcCtD
Doxazosin—Hepatitis—Doxorubicin—urinary bladder cancer	0.000268	0.00054	CcSEcCtD
Doxazosin—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000267	0.000538	CcSEcCtD
Doxazosin—Rash—Fluorouracil—urinary bladder cancer	0.000267	0.000537	CcSEcCtD
Doxazosin—Dermatitis—Fluorouracil—urinary bladder cancer	0.000266	0.000537	CcSEcCtD
Doxazosin—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000266	0.000536	CcSEcCtD
Doxazosin—Headache—Fluorouracil—urinary bladder cancer	0.000265	0.000534	CcSEcCtD
Doxazosin—Dysgeusia—Methotrexate—urinary bladder cancer	0.000264	0.000532	CcSEcCtD
Doxazosin—Asthenia—Etoposide—urinary bladder cancer	0.000263	0.000531	CcSEcCtD
Doxazosin—Back pain—Methotrexate—urinary bladder cancer	0.000261	0.000525	CcSEcCtD
Doxazosin—Chills—Epirubicin—urinary bladder cancer	0.00026	0.000524	CcSEcCtD
Doxazosin—Pruritus—Etoposide—urinary bladder cancer	0.00026	0.000524	CcSEcCtD
Doxazosin—Arrhythmia—Epirubicin—urinary bladder cancer	0.000259	0.000522	CcSEcCtD
Doxazosin—Visual impairment—Doxorubicin—urinary bladder cancer	0.000258	0.000521	CcSEcCtD
Doxazosin—Alopecia—Epirubicin—urinary bladder cancer	0.000256	0.000516	CcSEcCtD
Doxazosin—Nausea—Gemcitabine—urinary bladder cancer	0.000255	0.000515	CcSEcCtD
Doxazosin—Vomiting—Cisplatin—urinary bladder cancer	0.000255	0.000514	CcSEcCtD
Doxazosin—Vision blurred—Methotrexate—urinary bladder cancer	0.000254	0.000512	CcSEcCtD
Doxazosin—Mental disorder—Epirubicin—urinary bladder cancer	0.000254	0.000512	CcSEcCtD
Doxazosin—Rash—Cisplatin—urinary bladder cancer	0.000253	0.000509	CcSEcCtD
Doxazosin—Dermatitis—Cisplatin—urinary bladder cancer	0.000253	0.000509	CcSEcCtD
Doxazosin—Malnutrition—Epirubicin—urinary bladder cancer	0.000252	0.000508	CcSEcCtD
Doxazosin—Diarrhoea—Etoposide—urinary bladder cancer	0.000251	0.000506	CcSEcCtD
Doxazosin—Nausea—Fluorouracil—urinary bladder cancer	0.000251	0.000506	CcSEcCtD
Doxazosin—Eye disorder—Doxorubicin—urinary bladder cancer	0.000251	0.000505	CcSEcCtD
Doxazosin—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.00025	0.000504	CcSEcCtD
Doxazosin—Tinnitus—Doxorubicin—urinary bladder cancer	0.00025	0.000504	CcSEcCtD
Doxazosin—Flushing—Doxorubicin—urinary bladder cancer	0.000249	0.000501	CcSEcCtD
Doxazosin—Flatulence—Epirubicin—urinary bladder cancer	0.000249	0.000501	CcSEcCtD
Doxazosin—Tension—Epirubicin—urinary bladder cancer	0.000248	0.000499	CcSEcCtD
Doxazosin—Dysgeusia—Epirubicin—urinary bladder cancer	0.000247	0.000498	CcSEcCtD
Doxazosin—Nervousness—Epirubicin—urinary bladder cancer	0.000245	0.000494	CcSEcCtD
Doxazosin—Back pain—Epirubicin—urinary bladder cancer	0.000244	0.000492	CcSEcCtD
Doxazosin—Malaise—Methotrexate—urinary bladder cancer	0.000243	0.00049	CcSEcCtD
Doxazosin—Dizziness—Etoposide—urinary bladder cancer	0.000243	0.000489	CcSEcCtD
Doxazosin—Muscle spasms—Epirubicin—urinary bladder cancer	0.000242	0.000489	CcSEcCtD
Doxazosin—Vertigo—Methotrexate—urinary bladder cancer	0.000242	0.000488	CcSEcCtD
Doxazosin—Leukopenia—Methotrexate—urinary bladder cancer	0.000241	0.000486	CcSEcCtD
Doxazosin—Chills—Doxorubicin—urinary bladder cancer	0.000241	0.000485	CcSEcCtD
Doxazosin—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000239	0.000483	CcSEcCtD
Doxazosin—Nausea—Cisplatin—urinary bladder cancer	0.000238	0.00048	CcSEcCtD
Doxazosin—Vision blurred—Epirubicin—urinary bladder cancer	0.000238	0.000479	CcSEcCtD
Doxazosin—Alopecia—Doxorubicin—urinary bladder cancer	0.000237	0.000477	CcSEcCtD
Doxazosin—Cough—Methotrexate—urinary bladder cancer	0.000235	0.000474	CcSEcCtD
Doxazosin—Mental disorder—Doxorubicin—urinary bladder cancer	0.000235	0.000473	CcSEcCtD
Doxazosin—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000234	0.000472	CcSEcCtD
Doxazosin—Convulsion—Methotrexate—urinary bladder cancer	0.000234	0.000471	CcSEcCtD
Doxazosin—Vomiting—Etoposide—urinary bladder cancer	0.000233	0.000471	CcSEcCtD
Doxazosin—Malnutrition—Doxorubicin—urinary bladder cancer	0.000233	0.00047	CcSEcCtD
Doxazosin—Agitation—Epirubicin—urinary bladder cancer	0.000232	0.000467	CcSEcCtD
Doxazosin—Rash—Etoposide—urinary bladder cancer	0.000232	0.000467	CcSEcCtD
Doxazosin—Dermatitis—Etoposide—urinary bladder cancer	0.000231	0.000466	CcSEcCtD
Doxazosin—Headache—Etoposide—urinary bladder cancer	0.00023	0.000464	CcSEcCtD
Doxazosin—Flatulence—Doxorubicin—urinary bladder cancer	0.00023	0.000463	CcSEcCtD
Doxazosin—Arthralgia—Methotrexate—urinary bladder cancer	0.000229	0.000462	CcSEcCtD
Doxazosin—Chest pain—Methotrexate—urinary bladder cancer	0.000229	0.000462	CcSEcCtD
Doxazosin—Myalgia—Methotrexate—urinary bladder cancer	0.000229	0.000462	CcSEcCtD
Doxazosin—Tension—Doxorubicin—urinary bladder cancer	0.000229	0.000462	CcSEcCtD
Doxazosin—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000229	0.000461	CcSEcCtD
Doxazosin—Malaise—Epirubicin—urinary bladder cancer	0.000227	0.000458	CcSEcCtD
Doxazosin—Discomfort—Methotrexate—urinary bladder cancer	0.000227	0.000457	CcSEcCtD
Doxazosin—Nervousness—Doxorubicin—urinary bladder cancer	0.000227	0.000457	CcSEcCtD
Doxazosin—Vertigo—Epirubicin—urinary bladder cancer	0.000227	0.000457	CcSEcCtD
Doxazosin—Syncope—Epirubicin—urinary bladder cancer	0.000226	0.000456	CcSEcCtD
Doxazosin—Leukopenia—Epirubicin—urinary bladder cancer	0.000226	0.000455	CcSEcCtD
Doxazosin—Back pain—Doxorubicin—urinary bladder cancer	0.000226	0.000455	CcSEcCtD
Doxazosin—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000224	0.000452	CcSEcCtD
Doxazosin—Palpitations—Epirubicin—urinary bladder cancer	0.000223	0.000449	CcSEcCtD
Doxazosin—Confusional state—Methotrexate—urinary bladder cancer	0.000222	0.000447	CcSEcCtD
Doxazosin—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000222	0.000447	CcSEcCtD
Doxazosin—Cough—Epirubicin—urinary bladder cancer	0.00022	0.000444	CcSEcCtD
Doxazosin—Vision blurred—Doxorubicin—urinary bladder cancer	0.00022	0.000443	CcSEcCtD
Doxazosin—Convulsion—Epirubicin—urinary bladder cancer	0.000219	0.00044	CcSEcCtD
Doxazosin—Infection—Methotrexate—urinary bladder cancer	0.000219	0.00044	CcSEcCtD
Doxazosin—Nausea—Etoposide—urinary bladder cancer	0.000218	0.00044	CcSEcCtD
Doxazosin—Hypertension—Epirubicin—urinary bladder cancer	0.000218	0.000439	CcSEcCtD
Doxazosin—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000217	0.000436	CcSEcCtD
Doxazosin—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000215	0.000434	CcSEcCtD
Doxazosin—Myalgia—Epirubicin—urinary bladder cancer	0.000215	0.000433	CcSEcCtD
Doxazosin—Chest pain—Epirubicin—urinary bladder cancer	0.000215	0.000433	CcSEcCtD
Doxazosin—Arthralgia—Epirubicin—urinary bladder cancer	0.000215	0.000433	CcSEcCtD
Doxazosin—Agitation—Doxorubicin—urinary bladder cancer	0.000214	0.000432	CcSEcCtD
Doxazosin—Anxiety—Epirubicin—urinary bladder cancer	0.000214	0.000431	CcSEcCtD
Doxazosin—Skin disorder—Methotrexate—urinary bladder cancer	0.000214	0.000431	CcSEcCtD
Doxazosin—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000213	0.000429	CcSEcCtD
Doxazosin—Discomfort—Epirubicin—urinary bladder cancer	0.000212	0.000428	CcSEcCtD
Doxazosin—Malaise—Doxorubicin—urinary bladder cancer	0.00021	0.000424	CcSEcCtD
Doxazosin—Dry mouth—Epirubicin—urinary bladder cancer	0.00021	0.000423	CcSEcCtD
Doxazosin—Vertigo—Doxorubicin—urinary bladder cancer	0.00021	0.000423	CcSEcCtD
Doxazosin—Anorexia—Methotrexate—urinary bladder cancer	0.00021	0.000423	CcSEcCtD
Doxazosin—Syncope—Doxorubicin—urinary bladder cancer	0.000209	0.000422	CcSEcCtD
Doxazosin—Leukopenia—Doxorubicin—urinary bladder cancer	0.000209	0.000421	CcSEcCtD
Doxazosin—Confusional state—Epirubicin—urinary bladder cancer	0.000208	0.000418	CcSEcCtD
Doxazosin—Palpitations—Doxorubicin—urinary bladder cancer	0.000206	0.000416	CcSEcCtD
Doxazosin—Oedema—Epirubicin—urinary bladder cancer	0.000206	0.000415	CcSEcCtD
Doxazosin—Hypotension—Methotrexate—urinary bladder cancer	0.000206	0.000414	CcSEcCtD
Doxazosin—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000205	0.000413	CcSEcCtD
Doxazosin—Infection—Epirubicin—urinary bladder cancer	0.000205	0.000412	CcSEcCtD
Doxazosin—Cough—Doxorubicin—urinary bladder cancer	0.000204	0.00041	CcSEcCtD
Doxazosin—Shock—Epirubicin—urinary bladder cancer	0.000203	0.000408	CcSEcCtD
Doxazosin—Convulsion—Doxorubicin—urinary bladder cancer	0.000202	0.000408	CcSEcCtD
Doxazosin—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000202	0.000406	CcSEcCtD
Doxazosin—Hypertension—Doxorubicin—urinary bladder cancer	0.000201	0.000406	CcSEcCtD
Doxazosin—Tachycardia—Epirubicin—urinary bladder cancer	0.000201	0.000405	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.0002	0.000404	CcSEcCtD
Doxazosin—Skin disorder—Epirubicin—urinary bladder cancer	0.0002	0.000403	CcSEcCtD
Doxazosin—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000199	0.000401	CcSEcCtD
Doxazosin—Insomnia—Methotrexate—urinary bladder cancer	0.000199	0.000401	CcSEcCtD
Doxazosin—Myalgia—Doxorubicin—urinary bladder cancer	0.000199	0.0004	CcSEcCtD
Doxazosin—Chest pain—Doxorubicin—urinary bladder cancer	0.000199	0.0004	CcSEcCtD
Doxazosin—Arthralgia—Doxorubicin—urinary bladder cancer	0.000199	0.0004	CcSEcCtD
Doxazosin—Anxiety—Doxorubicin—urinary bladder cancer	0.000198	0.000399	CcSEcCtD
Doxazosin—Paraesthesia—Methotrexate—urinary bladder cancer	0.000198	0.000398	CcSEcCtD
Doxazosin—Discomfort—Doxorubicin—urinary bladder cancer	0.000196	0.000396	CcSEcCtD
Doxazosin—Anorexia—Epirubicin—urinary bladder cancer	0.000196	0.000395	CcSEcCtD
Doxazosin—Dyspnoea—Methotrexate—urinary bladder cancer	0.000196	0.000395	CcSEcCtD
Doxazosin—Somnolence—Methotrexate—urinary bladder cancer	0.000196	0.000394	CcSEcCtD
Doxazosin—Dry mouth—Doxorubicin—urinary bladder cancer	0.000194	0.000392	CcSEcCtD
Doxazosin—Dyspepsia—Methotrexate—urinary bladder cancer	0.000194	0.00039	CcSEcCtD
Doxazosin—Hypotension—Epirubicin—urinary bladder cancer	0.000192	0.000388	CcSEcCtD
Doxazosin—Confusional state—Doxorubicin—urinary bladder cancer	0.000192	0.000387	CcSEcCtD
Doxazosin—Decreased appetite—Methotrexate—urinary bladder cancer	0.000191	0.000385	CcSEcCtD
Doxazosin—Oedema—Doxorubicin—urinary bladder cancer	0.00019	0.000384	CcSEcCtD
Doxazosin—Fatigue—Methotrexate—urinary bladder cancer	0.00019	0.000382	CcSEcCtD
Doxazosin—Infection—Doxorubicin—urinary bladder cancer	0.000189	0.000381	CcSEcCtD
Doxazosin—Pain—Methotrexate—urinary bladder cancer	0.000188	0.000379	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000188	0.000378	CcSEcCtD
Doxazosin—Shock—Doxorubicin—urinary bladder cancer	0.000187	0.000378	CcSEcCtD
Doxazosin—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000186	0.000376	CcSEcCtD
Doxazosin—Insomnia—Epirubicin—urinary bladder cancer	0.000186	0.000375	CcSEcCtD
Doxazosin—Tachycardia—Doxorubicin—urinary bladder cancer	0.000186	0.000375	CcSEcCtD
Doxazosin—Skin disorder—Doxorubicin—urinary bladder cancer	0.000185	0.000373	CcSEcCtD
Doxazosin—Paraesthesia—Epirubicin—urinary bladder cancer	0.000185	0.000373	CcSEcCtD
Doxazosin—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000184	0.000371	CcSEcCtD
Doxazosin—Dyspnoea—Epirubicin—urinary bladder cancer	0.000184	0.00037	CcSEcCtD
Doxazosin—Somnolence—Epirubicin—urinary bladder cancer	0.000183	0.000369	CcSEcCtD
Doxazosin—Anorexia—Doxorubicin—urinary bladder cancer	0.000182	0.000366	CcSEcCtD
Doxazosin—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000181	0.000365	CcSEcCtD
Doxazosin—Dyspepsia—Epirubicin—urinary bladder cancer	0.000181	0.000365	CcSEcCtD
Doxazosin—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.00018	0.000362	CcSEcCtD
Doxazosin—Decreased appetite—Epirubicin—urinary bladder cancer	0.000179	0.000361	CcSEcCtD
Doxazosin—Hypotension—Doxorubicin—urinary bladder cancer	0.000178	0.000359	CcSEcCtD
Doxazosin—Fatigue—Epirubicin—urinary bladder cancer	0.000177	0.000358	CcSEcCtD
Doxazosin—Pain—Epirubicin—urinary bladder cancer	0.000176	0.000355	CcSEcCtD
Doxazosin—Constipation—Epirubicin—urinary bladder cancer	0.000176	0.000355	CcSEcCtD
Doxazosin—Urticaria—Methotrexate—urinary bladder cancer	0.000175	0.000352	CcSEcCtD
Doxazosin—Abdominal pain—Methotrexate—urinary bladder cancer	0.000174	0.00035	CcSEcCtD
Doxazosin—Body temperature increased—Methotrexate—urinary bladder cancer	0.000174	0.00035	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000174	0.00035	CcSEcCtD
Doxazosin—Insomnia—Doxorubicin—urinary bladder cancer	0.000172	0.000347	CcSEcCtD
Doxazosin—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000171	0.000345	CcSEcCtD
Doxazosin—Dyspnoea—Doxorubicin—urinary bladder cancer	0.00017	0.000342	CcSEcCtD
Doxazosin—Feeling abnormal—Epirubicin—urinary bladder cancer	0.00017	0.000342	CcSEcCtD
Doxazosin—Somnolence—Doxorubicin—urinary bladder cancer	0.000169	0.000341	CcSEcCtD
Doxazosin—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000168	0.000339	CcSEcCtD
Doxazosin—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000168	0.000338	CcSEcCtD
Doxazosin—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000166	0.000334	CcSEcCtD
Doxazosin—Fatigue—Doxorubicin—urinary bladder cancer	0.000164	0.000331	CcSEcCtD
Doxazosin—Urticaria—Epirubicin—urinary bladder cancer	0.000164	0.00033	CcSEcCtD
Doxazosin—Pain—Doxorubicin—urinary bladder cancer	0.000163	0.000328	CcSEcCtD
Doxazosin—Constipation—Doxorubicin—urinary bladder cancer	0.000163	0.000328	CcSEcCtD
Doxazosin—Abdominal pain—Epirubicin—urinary bladder cancer	0.000163	0.000328	CcSEcCtD
Doxazosin—Body temperature increased—Epirubicin—urinary bladder cancer	0.000163	0.000328	CcSEcCtD
Doxazosin—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000162	0.000327	CcSEcCtD
Doxazosin—Asthenia—Methotrexate—urinary bladder cancer	0.000158	0.000318	CcSEcCtD
Doxazosin—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000157	0.000316	CcSEcCtD
Doxazosin—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000156	0.000314	CcSEcCtD
Doxazosin—Pruritus—Methotrexate—urinary bladder cancer	0.000156	0.000314	CcSEcCtD
Doxazosin—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000152	0.000306	CcSEcCtD
Doxazosin—Urticaria—Doxorubicin—urinary bladder cancer	0.000151	0.000305	CcSEcCtD
Doxazosin—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000151	0.000303	CcSEcCtD
Doxazosin—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000151	0.000303	CcSEcCtD
Doxazosin—Diarrhoea—Methotrexate—urinary bladder cancer	0.000151	0.000303	CcSEcCtD
Doxazosin—Asthenia—Epirubicin—urinary bladder cancer	0.000148	0.000298	CcSEcCtD
Doxazosin—Pruritus—Epirubicin—urinary bladder cancer	0.000146	0.000294	CcSEcCtD
Doxazosin—Dizziness—Methotrexate—urinary bladder cancer	0.000145	0.000293	CcSEcCtD
Doxazosin—Diarrhoea—Epirubicin—urinary bladder cancer	0.000141	0.000284	CcSEcCtD
Doxazosin—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.00014	0.000283	CcSEcCtD
Doxazosin—Vomiting—Methotrexate—urinary bladder cancer	0.00014	0.000282	CcSEcCtD
Doxazosin—Rash—Methotrexate—urinary bladder cancer	0.000139	0.00028	CcSEcCtD
Doxazosin—Dermatitis—Methotrexate—urinary bladder cancer	0.000139	0.000279	CcSEcCtD
Doxazosin—Headache—Methotrexate—urinary bladder cancer	0.000138	0.000278	CcSEcCtD
Doxazosin—Asthenia—Doxorubicin—urinary bladder cancer	0.000137	0.000275	CcSEcCtD
Doxazosin—Dizziness—Epirubicin—urinary bladder cancer	0.000136	0.000274	CcSEcCtD
Doxazosin—Pruritus—Doxorubicin—urinary bladder cancer	0.000135	0.000272	CcSEcCtD
Doxazosin—Vomiting—Epirubicin—urinary bladder cancer	0.000131	0.000264	CcSEcCtD
Doxazosin—Nausea—Methotrexate—urinary bladder cancer	0.000131	0.000263	CcSEcCtD
Doxazosin—Diarrhoea—Doxorubicin—urinary bladder cancer	0.00013	0.000263	CcSEcCtD
Doxazosin—Rash—Epirubicin—urinary bladder cancer	0.00013	0.000262	CcSEcCtD
Doxazosin—Dermatitis—Epirubicin—urinary bladder cancer	0.00013	0.000261	CcSEcCtD
Doxazosin—Headache—Epirubicin—urinary bladder cancer	0.000129	0.00026	CcSEcCtD
Doxazosin—Dizziness—Doxorubicin—urinary bladder cancer	0.000126	0.000254	CcSEcCtD
Doxazosin—Nausea—Epirubicin—urinary bladder cancer	0.000122	0.000246	CcSEcCtD
Doxazosin—Vomiting—Doxorubicin—urinary bladder cancer	0.000121	0.000244	CcSEcCtD
Doxazosin—Rash—Doxorubicin—urinary bladder cancer	0.00012	0.000242	CcSEcCtD
Doxazosin—Dermatitis—Doxorubicin—urinary bladder cancer	0.00012	0.000242	CcSEcCtD
Doxazosin—Headache—Doxorubicin—urinary bladder cancer	0.000119	0.00024	CcSEcCtD
Doxazosin—Nausea—Doxorubicin—urinary bladder cancer	0.000113	0.000228	CcSEcCtD
Doxazosin—ABCB1—Metabolism—SLC19A1—urinary bladder cancer	8.02e-06	0.000826	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PRSS3—urinary bladder cancer	8.01e-06	0.000825	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—CYP4B1—urinary bladder cancer	8e-06	0.000824	CbGpPWpGaD
Doxazosin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—urinary bladder cancer	7.99e-06	0.000823	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PRSS3—urinary bladder cancer	7.82e-06	0.000805	CbGpPWpGaD
Doxazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—urinary bladder cancer	7.68e-06	0.000791	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	7.65e-06	0.000787	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—RBX1—urinary bladder cancer	7.56e-06	0.000779	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—SLC19A1—urinary bladder cancer	7.56e-06	0.000778	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—GLI1—urinary bladder cancer	7.56e-06	0.000778	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	7.4e-06	0.000762	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	7.38e-06	0.00076	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR ligand binding—CXCL8—urinary bladder cancer	7.38e-06	0.00076	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PRSS3—urinary bladder cancer	7.37e-06	0.000759	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—TSC1—urinary bladder cancer	7.11e-06	0.000732	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—RRM2—urinary bladder cancer	7.06e-06	0.000727	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	7.04e-06	0.000725	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—CREBBP—urinary bladder cancer	6.85e-06	0.000706	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	6.84e-06	0.000705	CbGpPWpGaD
Doxazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—urinary bladder cancer	6.82e-06	0.000702	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—IGF1—urinary bladder cancer	6.77e-06	0.000697	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—JAG1—urinary bladder cancer	6.77e-06	0.000697	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR ligand binding—CXCL8—urinary bladder cancer	6.55e-06	0.000675	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—ENO2—urinary bladder cancer	6.53e-06	0.000673	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—HPGDS—urinary bladder cancer	6.53e-06	0.000673	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	6.42e-06	0.000661	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—TYMP—urinary bladder cancer	6.4e-06	0.000659	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—GSTT1—urinary bladder cancer	6.34e-06	0.000653	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—RBX1—urinary bladder cancer	6.28e-06	0.000646	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—TYMP—urinary bladder cancer	6.25e-06	0.000644	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—RHOA—urinary bladder cancer	6.2e-06	0.000639	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	6.15e-06	0.000633	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	6.13e-06	0.000632	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR ligand binding—CXCL8—urinary bladder cancer	6.09e-06	0.000627	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	6e-06	0.000618	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—TSC1—urinary bladder cancer	5.9e-06	0.000608	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—TYMP—urinary bladder cancer	5.89e-06	0.000606	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—NAT2—urinary bladder cancer	5.79e-06	0.000596	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—RHOA—urinary bladder cancer	5.72e-06	0.000589	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	5.71e-06	0.000588	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	5.67e-06	0.000584	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—NAT2—urinary bladder cancer	5.65e-06	0.000582	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—JAG1—urinary bladder cancer	5.62e-06	0.000578	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—RBX1—urinary bladder cancer	5.57e-06	0.000574	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—S100B—urinary bladder cancer	5.48e-06	0.000564	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—NAT2—urinary bladder cancer	5.33e-06	0.000548	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—NQO1—urinary bladder cancer	5.27e-06	0.000542	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—TSC1—urinary bladder cancer	5.24e-06	0.00054	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—IL2—urinary bladder cancer	5.2e-06	0.000536	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—RHOA—urinary bladder cancer	5.2e-06	0.000535	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—RBX1—urinary bladder cancer	5.18e-06	0.000533	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	5.04e-06	0.000519	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—CXCL8—urinary bladder cancer	5.02e-06	0.000517	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—RRM2—urinary bladder cancer	5e-06	0.000515	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—JAG1—urinary bladder cancer	4.99e-06	0.000514	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—NCOR1—urinary bladder cancer	4.93e-06	0.000507	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—RRM2—urinary bladder cancer	4.88e-06	0.000502	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—TSC1—urinary bladder cancer	4.87e-06	0.000501	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—IL2—urinary bladder cancer	4.8e-06	0.000494	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—RHOA—urinary bladder cancer	4.75e-06	0.000489	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—EP300—urinary bladder cancer	4.67e-06	0.000481	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—JAG1—urinary bladder cancer	4.64e-06	0.000477	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	4.63e-06	0.000477	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—ENO2—urinary bladder cancer	4.63e-06	0.000477	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	4.6e-06	0.000474	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—RRM2—urinary bladder cancer	4.6e-06	0.000473	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—CXCL8—urinary bladder cancer	4.56e-06	0.00047	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—S100B—urinary bladder cancer	4.55e-06	0.000468	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—SRC—urinary bladder cancer	4.54e-06	0.000467	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—HPGDS—urinary bladder cancer	4.52e-06	0.000465	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—ENO2—urinary bladder cancer	4.52e-06	0.000465	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	4.49e-06	0.000462	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	4.42e-06	0.000455	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—GSTP1—urinary bladder cancer	4.39e-06	0.000452	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—GSTT1—urinary bladder cancer	4.38e-06	0.000451	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—IL2—urinary bladder cancer	4.36e-06	0.000449	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—TERT—urinary bladder cancer	4.34e-06	0.000447	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—RHOA—urinary bladder cancer	4.31e-06	0.000444	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—ENO2—urinary bladder cancer	4.26e-06	0.000438	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	4.26e-06	0.000438	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—RHOA—urinary bladder cancer	4.22e-06	0.000434	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—CXCL8—urinary bladder cancer	4.17e-06	0.000429	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	4.13e-06	0.000425	CbGpPWpGaD
Doxazosin—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	4.1e-06	0.000423	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—NCOR1—urinary bladder cancer	4.09e-06	0.000421	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—TYMS—urinary bladder cancer	4.08e-06	0.000421	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—S100B—urinary bladder cancer	4.04e-06	0.000416	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—NCOR1—urinary bladder cancer	4.04e-06	0.000416	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—GSTM1—urinary bladder cancer	4.04e-06	0.000416	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—FGFR3—urinary bladder cancer	3.99e-06	0.00041	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—IL2—urinary bladder cancer	3.98e-06	0.00041	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—RHOA—urinary bladder cancer	3.92e-06	0.000404	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—ESR1—urinary bladder cancer	3.87e-06	0.000399	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—GPX1—urinary bladder cancer	3.87e-06	0.000398	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—RHOA—urinary bladder cancer	3.83e-06	0.000394	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—ERCC2—urinary bladder cancer	3.8e-06	0.000391	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—CXCL8—urinary bladder cancer	3.79e-06	0.00039	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—KRAS—urinary bladder cancer	3.76e-06	0.000387	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—S100B—urinary bladder cancer	3.75e-06	0.000387	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—NQO1—urinary bladder cancer	3.73e-06	0.000384	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—CXCL8—urinary bladder cancer	3.7e-06	0.000381	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—NQO1—urinary bladder cancer	3.64e-06	0.000375	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—NCOR1—urinary bladder cancer	3.63e-06	0.000374	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	3.62e-06	0.000373	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—IL2—urinary bladder cancer	3.62e-06	0.000373	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—TERT—urinary bladder cancer	3.6e-06	0.000371	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—MTHFR—urinary bladder cancer	3.57e-06	0.000367	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—RHOA—urinary bladder cancer	3.56e-06	0.000366	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—IL2—urinary bladder cancer	3.54e-06	0.000364	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—CXCL8—urinary bladder cancer	3.44e-06	0.000354	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—NQO1—urinary bladder cancer	3.43e-06	0.000353	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—CREBBP—urinary bladder cancer	3.39e-06	0.000349	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—NCOR1—urinary bladder cancer	3.38e-06	0.000348	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—CXCL8—urinary bladder cancer	3.36e-06	0.000346	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—IGF1—urinary bladder cancer	3.35e-06	0.000345	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—TP53—urinary bladder cancer	3.34e-06	0.000344	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—EGFR—urinary bladder cancer	3.33e-06	0.000343	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—FGFR3—urinary bladder cancer	3.31e-06	0.000341	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—IL2—urinary bladder cancer	3.29e-06	0.000339	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—IL2—urinary bladder cancer	3.21e-06	0.000331	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—ESR1—urinary bladder cancer	3.21e-06	0.000331	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—TERT—urinary bladder cancer	3.2e-06	0.00033	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—HRAS—urinary bladder cancer	3.19e-06	0.000329	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	3.16e-06	0.000325	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—KRAS—urinary bladder cancer	3.15e-06	0.000324	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—CXCL8—urinary bladder cancer	3.12e-06	0.000322	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	3.11e-06	0.00032	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—RHOA—urinary bladder cancer	3.07e-06	0.000316	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—GSTP1—urinary bladder cancer	3.04e-06	0.000313	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	3.01e-06	0.00031	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—IL2—urinary bladder cancer	2.99e-06	0.000307	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—TERT—urinary bladder cancer	2.97e-06	0.000306	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—FGFR3—urinary bladder cancer	2.94e-06	0.000303	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—TYMS—urinary bladder cancer	2.89e-06	0.000298	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—PPARG—urinary bladder cancer	2.89e-06	0.000298	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	2.86e-06	0.000295	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	2.86e-06	0.000294	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	2.86e-06	0.000294	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—ESR1—urinary bladder cancer	2.85e-06	0.000294	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—ERBB2—urinary bladder cancer	2.84e-06	0.000293	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—TYMS—urinary bladder cancer	2.82e-06	0.000291	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CREBBP—urinary bladder cancer	2.82e-06	0.00029	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—GSTM1—urinary bladder cancer	2.79e-06	0.000287	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—NCOR1—urinary bladder cancer	2.79e-06	0.000287	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—IGF1—urinary bladder cancer	2.78e-06	0.000286	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—CREBBP—urinary bladder cancer	2.78e-06	0.000286	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—EGFR—urinary bladder cancer	2.77e-06	0.000285	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—GPX1—urinary bladder cancer	2.74e-06	0.000282	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—FGFR3—urinary bladder cancer	2.73e-06	0.000281	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—CXCL8—urinary bladder cancer	2.69e-06	0.000277	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	2.69e-06	0.000277	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—HRAS—urinary bladder cancer	2.68e-06	0.000276	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—GPX1—urinary bladder cancer	2.67e-06	0.000275	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—TYMS—urinary bladder cancer	2.66e-06	0.000274	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—ESR1—urinary bladder cancer	2.65e-06	0.000273	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	2.63e-06	0.000271	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	2.63e-06	0.000271	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—ERCC2—urinary bladder cancer	2.62e-06	0.00027	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—KRAS—urinary bladder cancer	2.61e-06	0.000269	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—IL2—urinary bladder cancer	2.57e-06	0.000265	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—RHOA—urinary bladder cancer	2.55e-06	0.000262	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	2.53e-06	0.00026	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—GPX1—urinary bladder cancer	2.52e-06	0.000259	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—CCND1—urinary bladder cancer	2.51e-06	0.000258	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CREBBP—urinary bladder cancer	2.5e-06	0.000258	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	2.47e-06	0.000255	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—IGF1—urinary bladder cancer	2.47e-06	0.000254	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—MTHFR—urinary bladder cancer	2.47e-06	0.000254	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—EGFR—urinary bladder cancer	2.46e-06	0.000253	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—MMP9—urinary bladder cancer	2.44e-06	0.000251	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—CDKN1A—urinary bladder cancer	2.43e-06	0.00025	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—PTEN—urinary bladder cancer	2.42e-06	0.000249	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—ERBB2—urinary bladder cancer	2.36e-06	0.000243	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	2.32e-06	0.000239	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CREBBP—urinary bladder cancer	2.32e-06	0.000239	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—KRAS—urinary bladder cancer	2.32e-06	0.000239	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—EP300—urinary bladder cancer	2.31e-06	0.000238	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—IGF1—urinary bladder cancer	2.29e-06	0.000236	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—EGFR—urinary bladder cancer	2.28e-06	0.000235	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—PTGS2—urinary bladder cancer	2.28e-06	0.000234	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—RHOA—urinary bladder cancer	2.26e-06	0.000233	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—SRC—urinary bladder cancer	2.25e-06	0.000231	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CXCL8—urinary bladder cancer	2.24e-06	0.00023	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—HRAS—urinary bladder cancer	2.22e-06	0.000229	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—KRAS—urinary bladder cancer	2.16e-06	0.000222	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—IL2—urinary bladder cancer	2.14e-06	0.00022	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—RHOA—urinary bladder cancer	2.1e-06	0.000216	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—ERBB2—urinary bladder cancer	2.09e-06	0.000216	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CCND1—urinary bladder cancer	2.08e-06	0.000215	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PPARG—urinary bladder cancer	2.05e-06	0.000211	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—MMP9—urinary bladder cancer	2.02e-06	0.000208	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CDKN1A—urinary bladder cancer	2.02e-06	0.000208	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—MYC—urinary bladder cancer	2.01e-06	0.000207	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—PTEN—urinary bladder cancer	2.01e-06	0.000207	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PPARG—urinary bladder cancer	2e-06	0.000206	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CXCL8—urinary bladder cancer	1.99e-06	0.000205	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—PTEN—urinary bladder cancer	1.98e-06	0.000204	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—HRAS—urinary bladder cancer	1.97e-06	0.000203	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—EGFR—urinary bladder cancer	1.97e-06	0.000203	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	1.97e-06	0.000203	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—ERBB2—urinary bladder cancer	1.95e-06	0.0002	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—CREBBP—urinary bladder cancer	1.92e-06	0.000198	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—EP300—urinary bladder cancer	1.92e-06	0.000197	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—IL2—urinary bladder cancer	1.9e-06	0.000195	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—EP300—urinary bladder cancer	1.89e-06	0.000195	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PPARG—urinary bladder cancer	1.89e-06	0.000194	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—SRC—urinary bladder cancer	1.86e-06	0.000192	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—KRAS—urinary bladder cancer	1.86e-06	0.000192	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CCND1—urinary bladder cancer	1.85e-06	0.000191	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CXCL8—urinary bladder cancer	1.85e-06	0.00019	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—HRAS—urinary bladder cancer	1.83e-06	0.000189	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	1.81e-06	0.000186	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—MMP9—urinary bladder cancer	1.8e-06	0.000185	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CDKN1A—urinary bladder cancer	1.79e-06	0.000184	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PTEN—urinary bladder cancer	1.79e-06	0.000184	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—IL2—urinary bladder cancer	1.76e-06	0.000182	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CCND1—urinary bladder cancer	1.72e-06	0.000177	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—EP300—urinary bladder cancer	1.7e-06	0.000175	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—MYC—urinary bladder cancer	1.67e-06	0.000172	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—MMP9—urinary bladder cancer	1.67e-06	0.000172	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CDKN1A—urinary bladder cancer	1.66e-06	0.000171	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PTEN—urinary bladder cancer	1.66e-06	0.000171	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—SRC—urinary bladder cancer	1.66e-06	0.000171	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—TP53—urinary bladder cancer	1.65e-06	0.00017	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—EGFR—urinary bladder cancer	1.63e-06	0.000168	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	1.61e-06	0.000166	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—EP300—urinary bladder cancer	1.58e-06	0.000163	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—HRAS—urinary bladder cancer	1.58e-06	0.000163	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PTGS2—urinary bladder cancer	1.57e-06	0.000162	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—KRAS—urinary bladder cancer	1.54e-06	0.000159	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—SRC—urinary bladder cancer	1.54e-06	0.000158	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—MYC—urinary bladder cancer	1.48e-06	0.000153	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	1.48e-06	0.000153	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—EGFR—urinary bladder cancer	1.45e-06	0.000149	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PTEN—urinary bladder cancer	1.41e-06	0.000145	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—MYC—urinary bladder cancer	1.38e-06	0.000142	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PTEN—urinary bladder cancer	1.37e-06	0.000141	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—TP53—urinary bladder cancer	1.37e-06	0.000141	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—KRAS—urinary bladder cancer	1.37e-06	0.000141	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—EGFR—urinary bladder cancer	1.35e-06	0.000139	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—EP300—urinary bladder cancer	1.34e-06	0.000138	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—HRAS—urinary bladder cancer	1.31e-06	0.000135	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—EP300—urinary bladder cancer	1.31e-06	0.000135	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PTEN—urinary bladder cancer	1.29e-06	0.000133	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—KRAS—urinary bladder cancer	1.27e-06	0.000131	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—EP300—urinary bladder cancer	1.23e-06	0.000127	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—TP53—urinary bladder cancer	1.22e-06	0.000126	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—HRAS—urinary bladder cancer	1.17e-06	0.00012	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—TP53—urinary bladder cancer	1.13e-06	0.000117	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—HRAS—urinary bladder cancer	1.08e-06	0.000112	CbGpPWpGaD
